Relationship between neutralizing antibody and liver-mediated factor IX expression in non-human primates using AAV vectors

被引：0
|
作者：
Mizukami, Hiroaki
Mimuro, Jun
Ishiwata, Akira
Ono, Fumiko [1 ]
Yagi, Hiroya
Urabe, Masashi
Kume, Akihiro
Terao, Keiji [1 ]
Yasutomi, Yasuhiro [1 ]
Sakata, Yoichi
Ozawa, Keiya
机构：
[1] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan
来源：
HUMAN GENE THERAPY | 2009年 / 20卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1481 / 1482
页数：2
相关论文
共 50 条
  • [21] Effect of Neutralizing Anti-AAV Antibodies on Vector Transduction Following Intravitreal Administration of AAV in Non-Human Primates
    Turunen, Heikki
    Timmers, Adrian M.
    Newmark, Judith
    Pennock, Steven
    Shearman, Mark S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [22] Persistent expression of human coagulation factor IX following administration of AAV vectors to mouse muscle and liver.
    Nakai, H
    Herzog, R
    Iwaki, Y
    Colosi, P
    Eisensmith, R
    High, K
    Kurtzman, G
    Couto, L
    BLOOD, 1997, 90 (10) : 1055 - 1055
  • [23] Neutralizing antibody assay for use with non-human primates exposed to a recombinant human protein.
    VanCleave, V
    Murphy, K
    Ketchum, M
    Murray, K
    Celniker, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1130 - 1130
  • [24] Utility of microminipigs for evaluating liver-mediated gene expression in the presence of neutralizing antibody against vector capsid
    Watano, Ryota
    Ohmori, Tsukasa
    Hishikawa, Shuji
    Sakata, Asuka
    Mizukami, Hiroaki
    GENE THERAPY, 2020, 27 (09) : 427 - 434
  • [25] Gene Delivery to Non-Human Primate Embryos Using AAV Vectors
    Wang, Dan
    Niu, Yuyu
    Ren, Lingzhi
    Tai, Phillip W. L.
    Ji, Weizhi
    Gao, Guangping
    MOLECULAR THERAPY, 2019, 27 (04) : 110 - 110
  • [26] Utility of microminipigs for evaluating liver-mediated gene expression in the presence of neutralizing antibody against vector capsid
    Ryota Watano
    Tsukasa Ohmori
    Shuji Hishikawa
    Asuka Sakata
    Hiroaki Mizukami
    Gene Therapy, 2020, 27 : 427 - 434
  • [27] Dose response results of self complementary adeno-associated virus (AAV) vector-mediated factor IX gene transfer in non-human primates
    Reiss, Ulrike
    Davidoff, Andrew
    Gray, John
    Nienhuis, Arthur
    Nathwani, Amit
    HAEMOPHILIA, 2009, 15 (02) : 635 - 635
  • [28] In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles
    Dissen, Gregory A.
    Lomniczi, Alejandro
    Neff, Tanaya L.
    Hobbs, Theodore R.
    Kohama, Steven G.
    Kroenke, Christopher D.
    Galimi, Francesco
    Ojeda, Sergio R.
    METHODS, 2009, 49 (01) : 70 - 77
  • [29] AAV5-mediated gene transfer to the parotid glands of non-human primates
    Voutetakis, A.
    Zheng, C.
    Cotrim, A. P.
    Mineshiba, F.
    Afione, S.
    Roescher, N.
    Swaim, W. D.
    Metzger, M.
    Eckhaus, M. A.
    Donahue, R. E.
    Dunbar, C. E.
    Chiorini, J. A.
    Baum, B. J.
    GENE THERAPY, 2010, 17 (01) : 50 - 60
  • [30] AAV5-mediated gene transfer to the parotid glands of non-human primates
    A Voutetakis
    C Zheng
    A P Cotrim
    F Mineshiba
    S Afione
    N Roescher
    W D Swaim
    M Metzger
    M A Eckhaus
    R E Donahue
    C E Dunbar
    J A Chiorini
    B J Baum
    Gene Therapy, 2010, 17 : 50 - 60
12345